PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• P21-activated kinase 4 (PAK4) is implicated in cell adhesion dynamics, often linked to its kinase activity and Cdc42 binding.
• Elevated PAK4 expression is observed in high-grade human breast cancers, suggesting a role in tumorigenesis.

Purpose of the Study:

• To elucidate the precise mechanism of PAK4's function in regulating cell adhesion and migration.
• To investigate the relationship between PAK4, Cdc42, kinase activity, and RhoU in breast cancer cells.

Main Methods:

• Analysis of PAK4 expression in human breast cancer samples.
• Depletion of PAK4 in breast cancer cells to observe effects on cell adhesion dynamics.
• Systematic functional analysis of PAK4, including Cdc42 binding and kinase activity assays.
• Investigation of RhoU expression and its regulation by PAK4.
• Ubiquitination assays involving the Rab40A-Cullin 5 complex and RhoU.
• Rescue experiments with RhoU overexpression and RhoU loss-of-function studies.

Main Results:

• PAK4 expression is significantly higher in high-grade breast cancer.
• PAK4-mediated adhesion turnover is independent of Cdc42 binding and kinase activity.
• PAK4 depletion leads to reduced RhoU expression.
• PAK4 protects RhoU from ubiquitination by the Rab40A-Cullin 5 complex in a kinase-independent manner.
• RhoU overexpression rescues the PAK4 depletion phenotype, while RhoU loss reduces cell adhesion turnover and migration.

Conclusions:

• PAK4 regulates cell adhesion and migration through a novel kinase-independent mechanism involving RhoU stabilization.
• PAK4 protects RhoU from ubiquitination and degradation, thereby maintaining its protein levels.
• PAK4 and RhoU function cooperatively to drive adhesion turnover and promote breast cancer cell migration.